rtx1 users’ e-symposium 2022

Imagine Eyes organizes a rtx1 users’ e-symposium on May 30th, 2022, at 4pm CEST. In a 90min meeting, users of Imagine Eyes’ adaptive optics (AO) technology will share about their experience with cellular and microvascular retinal imaging in clinical settings.

This symposium will be chaired by Prof. Paulo E. Stanga and Dr. Daniela Bacherini. Several participants will present recent progress made with rtx1 AO cameras (results of clincial studies and case reports) as well as an update on ongoing technology developments at Imagine Eyes. There will be time for questions and discussions.

 

Chairs

Program

Welcome

Session 1 – rtx1 in Retinitis Pigmentosa

  • AO ophthalmoscopy in RP: typical patterns. Friederike Kortuem, University Hospital of Tuebingen (GER)
  • Photoreceptor features in RP with macular edema using AO fundus camera. Shohei Kitahata, Department of Ophthalmology and Micro-technology, Yokohama City University (JP)
  • Early detection of localized cone loss in female carriers of RPGR mutations using adaptive optics imaging. Danial Roshandel, Lions Eye Institute, Perth (AUS)
  • Q&A discussion

Session 2 – Case reports

  • Acute macular neuroretinopathy. Toshio Mori, Nagoya Chukyo Hospital (JP)
  • Puffy cones. Hassan Khojasteh, Byers Eye Institute, Stanford University (USA)
  • AO and multimodal imaging follow-up of CSR with RPE changes. Ursula Reinstein, The Retina Clinic London (UK)
  • AO in syphilitic retinopathy. Stephano Mercuri, AOU Careggi Teaching Hospital, Florence (IT)
  • Q&A discussion

Session 3 – Ongoing technology developments

  • What’s coming in rtx1? Marine Durand, Imagine Eyes (FR)
  • Multimodal multiscale imaging – first clinical results. Kiyoko Gocho, Quinze-Vingts National Eye Hospital (FR)
  • Q&A discussion

Session 4 – rtx1 in AMD, diabetes and inflammation

  • AO phenotypes in intermediate AMD. Sobha Sivaprasad, Moorfields Eye Hospital, London (UK)
  • Enhanced visualization and progression tracking of gaze dependent features in AOO. Nathaniel Norberg, Quinze-Vingts National Eye Hospital, Paris (FR)
  • Microvascular features on AO imaging in diabetes. Irina-Elena Cristescu, Retina Clinic, Bucharest (ROM)
  • AO and multimodal imaging for inflammatory vitreoretinal interface abnormalities. Marie-Hélène Errera, University of Pittsburgh School of Medicine (US)
  • Q&A discussion

Concluding remarks